ロード中...
Availability of Authorizations from EMA and FDA for Age-Appropriate Medicines Contained in the WHO Essential Medicines List for Children 2019
Lack of age-appropriate commercially drug products availability is a common problem in pediatric therapeutics; this population needs improved and safer drug delivery. In addition, biopharmaceutic aspects, dosage requirements, and swallowing abilities demand pediatric forms different to adult formula...
保存先:
| 出版年: | Pharmaceutics |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7238124/ https://ncbi.nlm.nih.gov/pubmed/32244848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12040316 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|